Methods for Measuring Aggregate Costs of Conflict

This paper reviews the methods for measuring the economic cost of conflict. Estimating the economic costs of conflict requires a counterfactual calculation, which makes this a very difficult task. Social researchers have resorted to different estimation methods depending on the particular effect in question. The method used in each case depends on the units being analyzed (firms, sectors, regions or countries), the outcome variable under study (aggregate output, market valuation of firms, market shares, etc.) and data availability (a single cross-section, time series or panel data). This paper reviews existing methods used in the literature to assess the economic impact of conflict: cost accounting, cross-section methods, time series methods, panel data methods, gravity models, event studies, natural experiments and comparative case studies. The paper ends with a discussion of cost estimates and directions for further research.

Dynamic Inefficiency in an Overlapping Generation Economy with Pollution and Health Costs

Revised 2008-08.-- Published as an article in: Journal of Public Economic Theory (2008), 10(4), 563-594.

In vitro activities of natural products against oral Candida isolates from denture wearers

Background: Candida-associated denture stomatitis is a frequent infectious disease. Treatment of this oral condition is difficult because failures and recurrences are common. The aim of this study was to test the in vitro antifungal activity of pure constituents of essentials oils. -- Methods: Eight terpenic derivatives (carvacrol, farnesol, geraniol, linalool, menthol, menthone, terpinen-4-ol, and aterpineol), a phenylpropanoid (eugenol), a phenethyl alcohol (tyrosol) and fluconazole were evaluated against 38 Candida isolated from denture-wearers and 10 collection Candida strains by the CLSI M27-A3 broth microdilution method. -- Results: Almost all the tested compounds showed antifungal activity with MIC ranges of 0.03-0.25% for eugenol and linalool, 0.03-0.12% for geraniol, 0.06-0.5% for menthol, a-terpineol and terpinen-4-ol, 0.03-0.5% for carvacrol, and 0.06-4% for menthone. These compounds, with the exception of farnesol, menthone and tyrosol, showed important in vitro activities against the fluconazole-resistant and susceptible-dose dependent Candida isolates. -- Conclusions: Carvacrol, eugenol, geraniol, linalool and terpinen-4-ol were very active in vitro against oral Candida isolates. Their fungistatic and fungicidal activities might convert them into promising alternatives for the topic treatment of oral candidiasis and denture stomatitis.

Neuroprotective Effect of Melatonin: A Novel Therapy against Perinatal Hypoxia-Ischemia

17 p.

Linking Reduced Deforestation and a Global Carbon Market: Impacts on Costs, Financial Flows, and Technological Innovation

25 p.

The Costs of Ecosystem Adaptation: Methodology and Estimates for Indian Forests

34 p.

Long Run Trends in Energy-Related External Costs

30 p.

Regional IAM: analysis of risk-adjusted costs and benefits of climate policies

23 p.

The economics of hydro-meteorological disasters: approaching the estimation of the total costs

21 p.

The Costs of Drought: the Exceptional 2007-2008 Case of Barcelona

35 p.

Análisis y mejora de la gestión y organización del equipo Formula Student Bizkaia usando como referencia el modelo EFQM

[ES]El presente trabajo de fin de grado tiene como objetivo analizar y mejorar la gestión y organización del equipo Formula Student Bizkaia, de tal manera que le permita ser más competitivo frente al resto de universidades. Para su realización, en primer lugar, se exponen las distintas alternativas que existen para evaluar la calidad de gestión del equipo. En segundo lugar, una vez se haya escogido el modelo más conveniente, se prosigue al estudio de los distintos criterios clave en los que se basa. En tercer lugar, cuando se haya llevado a cabo el estudio de los puntos fuertes, así como evidencias y áreas a mejorar, se procede a realizar una evaluación que permita determinar las fortalezas y debilidades, para de esta manera potenciarlas y solventarlas, respectivamente. Por último, se presenta un desglose de los gastos que conlleva realizar la elaboración de un estudio de estas características, así como un desglose de las diferentes tareas a llevar a cabo y su respectiva duración.

Reciclado de polvo inconel 718 y evolución de las propiedades de los componentes fabricados con los mismos.

[ES]El objetivo de este trabajo ha sido la determinación de un proceso para la reutilización del polvo metálico desperdiciado durante el proceso de aporte por láser. El polvo necesita ser inyectado para ser fundido directamente sobre el aporte pero un alto porcentaje de las partículas golpean el área no fundida y directamente rebotan fuera de la zona de aporte. La eficiencia de las partículas depositadas puede bajar hasta el 40 % dependiendo de la configuración y del tamaño del punto de aporte. El material utilizado ha sido la superaleación de níquel Inconel 718 debido a su potencial aplicación en procesos de fabricación aditiva. Después del primer uso, el polvo es recolectado y tamizado. La fracción indeseada es magnéticamente segregada y la parte limpia es nuevamente tamizada para obtener datos y de nuevo mezclada para estar lista para la reutilización. No ha sido añadido polvo nuevo a la fracción recuperada y este procedimiento ha sido repetido 5 veces. Los test experimentales muestran que el material depositado presenta resultados similares a aquellos obtenidos con polvo nuevo. La implementación de este proceso permite la mejora de la eficiencia final reduciendo tanto costes como residuos materiales.

Lipid Nanoparticles as Carriers for RNAi against Viral Infections: Current Status and Future Perspectives

The efforts made to develop RNAi-based therapies have led to productive research in the field of infections in humans, such as hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), human cytomegalovirus (HCMV), herpetic keratitis, human papillomavirus, or influenza virus. Naked RNAi molecules are rapidly digested by nucleases in the serum, and due to their negative surface charge, entry into the cell cytoplasm is also hampered, which makes necessary the use of delivery systems to exploit the full potential of RNAi therapeutics. Lipid nanoparticles (LNP) represent one of the most widely used delivery systems for in vivo application of RNAi due to their relative safety and simplicity of production, joint with the enhanced payload and protection of encapsulated RNAs. Moreover, LNP may be functionalized to reach target cells, and they may be used to combine RNAi molecules with conventional drug substances to reduce resistance or improve efficiency. This review features the current application of LNP in RNAi mediated therapy against viral infections and aims to explore possible future lines of action in this field.

Postantifungal Effect of Micafungin against the Species Complexes of Candida albicans and Candida parapsilosis

Micafungin is an effective antifungal agent useful for the therapy of invasive candidiasis. Candida albicans is the most common cause of invasive candidiasis; however, infections due to non-C. albicans species, such as Candida parapsilosis, are rising. Killing and postantifungal effects (PAFE) are important factors in both dose interval choice and infection outcome. The aim of this study was to determinate the micafungin PAFE against 7 C. albicans strains, 5 Candida dubliniensis, 2 Candida Africana, 3 C. parapsilosis, 2 Candida metapsilosis and 2 Candida orthopsilosis. For PAFE studies, cells were exposed to micafungin for 1 h at concentrations ranging from 0.12 to 8 mu g/ml. Time-kill experiments (TK) were conducted at the same concentrations. Samples were removed at each time point (0-48 h) and viable counts determined. Micafungin (2 mu g/ml) was fungicidal (>= 3 log(10) reduction) in TK against 5 out of 14 (36%) strains of C. albicans complex. In PAFE experiments, fungicidal endpoint was achieved against 2 out of 14 strains (14%). In TK against C. parapsilosis, 8 mu g/ml of micafungin turned out to be fungicidal against 4 out 7 (57%) strains. Conversely, fungicidal endpoint was not achieved in PAFE studies. PAFE results for C. albicans complex (41.83 +/- 2.18 h) differed from C. parapsilosis complex (8.07 +/- 4.2 h) at the highest tested concentration of micafungin. In conclusion, micafungin showed significant differences in PAFE against C. albicans and C. parapsilosis complexes, being PAFE for the C. albicans complex longer than for the C. parapsilosis complex.